CAS 9004-61-9 API Powder Pure Sodium Hyaluronate Acid
Phone Number : 86-15209233790
WhatsApp : +8615209233790
Minimum Order Quantity : | 1kg, 25kg/drum, sample is available | Packaging Details : | Vacuum Aluminum Foil Bag; Fiber Drum for 25kg with inside double layer food grade poly bag |
---|---|---|---|
Delivery Time : | 5-7 working days | Payment Terms : | T/T, Western Union, Pay Pal, Alibaba Assurance Account |
Place of Origin: | China | Brand Name: | Xi'an Le-Nutra |
---|---|---|---|
Certification: | FDA,ISO9001,HACCP,HALAL,KOSHER etc |
Detail Information |
|||
CAS No.: | 33818-15-4 | Grade: | Pharmaceutical Grade |
---|---|---|---|
Citicoline Sodium: | ≥98% | Appearance: | White Crystals Or Crytalline Powder, Odorless |
Solubility: | Soluble In Water, Insoluble In Ethanol, Insoluble In Acetone | Molecular Formula: | C14H25N4NaO11P2 |
Molecular Weight: | 512.32 | Effect: | It Enhances The Function Of The Upstream Reticular Activation System Of The Brainstem, Strengthens The Function Of The Vertebral System And Improves Motor Paralysis, So It Has A Certain Effect On Promoting The Recovery Of Brain Function And Promoting Awake |
High Light: | 98% API Pharmaceutical Powder,CDPC Citicoline Sodium Pharmaceutical Powder,Nucleic Acid Pharmaceutical Powder |
Product Description
Product Information of API Powder
Sodium cytophosphatidylcholine is a nucleic acid derivative. it was discovered by Geiger in 1956 that it could restore brain damage in animal tests; in 1957, Kennedy's research confirmed its significance in cerebral phospholipid synthesis. in 1961, it was developed and manufactured by Takeda Pharmaceuticals in Japan and registered in China in 1988. It is presently the best-selling drug clinically used to treat brain disorders and is instrumental in the synthesis of lecithin, which improves brain function by promoting the synthesis of lecithin. It is proven that cytarabine can increase the level of norepinephrine and dopamine in the central nervous system, thus treating cerebrovascular disease, traumatic brain injury and cognitive impairment from various causes of chemical books without significant side effects.
Certificate of Analysis
Product Name | Citicoline Sodium |
CAS No. | 33818-15-4 |
Analysis Standard | ChP 2020 Part II |
Grade | Pharmaceutical grade |
Item | Standard | Test Result |
Citicoline Sodium | ≥98% | 100.2% |
Appearance | White crystals or crystalline powder, odorless | Complies |
Ammonium | ≤0.05% | Complies |
Phosphate | ≤0.1% | Complies |
Iron | ≤0.01% | Complies |
Chloride | ≤0.05% | Complies |
PH | 6.0-7.5 | 6.6 |
Solubility | Soluble in water, insoluble in ethanol, insoluble in acetone | |
Loss on Drying | ≤6% | 1.6% |
Heavy Metal | ≤5ppm | Complies |
Arsenic | ≤0.0001% | Complies |
Related substance | ||
5’-CMP | ≤0.3% | 0.023% |
Other single impurity | ≤0.2% | |
Other total impurities | ≤0.7% | 0.011% |
Residual solvents | ||
Methanol | ≤0.3% | Not detected |
Ethanol | ≤0.5% | 0.003% |
Acetone | ≤0.5% | Not detected |
Bacterial endotoxins | <0.3EU/mg | Complies |
Pharmacological Effects of API Powder
Citicoline Sodium strengthens the brainstem reticular formation, particularly activating systems in the superior reticular formation, which is closely related to consciousness, potentiates the action of the pyramidal system, and inhibits the action of the of the extrastriate system to encourage arousal. It can also decrease cerebrovascular resistance, and increase the perfusion of cerebral blood flow and stimulate the metabolism of brain substances. It is used primarily to treat neurological sequelae caused by craniocerebral injuries and cerebrovascular accidents, and can be used to treat Parkinson's syndrome and has certain efficacy in Alzheimer's disease; it is used to treat cerebrovascular and cardiovascular diseases; others such as delaying aging and improving learning effectiveness and memory also have certain efficacy.
Cytidine 5'-bis-choline phosphate (CDP-choline), which supports the synthesis of lecithin, is produced in choline-phosphate cytidylyltransferase EC 2.7.7.15; used to study its role in neurorehabilitation.
Enter Your Message